The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Craze Ground Truths FDA's Overreach on Compounded Peptides The FDA just made a move that changes everything for my patients. For nearly two years, some of the most clinically promising peptides in longevity and autoimmune medicine were locked away Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress